
CARBOGEN AMCIS AG., has entered into a co-investment agreement of more than CHF 25 million with a key client to expand ...
DISHMAN CARBOGEN AMCIS LIMITED's subsidiary, CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, is pleased to announce a strategic co-investment of more than CHF …